Healthcare -
Biotechnology - NASDAQ - US
$ 0.492
0 %
$ 121 M
Market Cap
-1.37
P/E
SGMO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SGMO - Sangamo Therapeutics, Inc.
28.4 M
LAST VALUE
-42.10%
2 YEAR CAGR
-27.54%
5 YEAR CAGR
-12.02%
10 YEAR CAGR